Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1993 Feb;31(2):192–197. doi: 10.1128/jcm.31.2.192-197.1993

Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.

L Dillner 1, A Fredriksson 1, E Persson 1, O Forslund 1, B G Hansson 1, J Dillner 1
PMCID: PMC262734  PMID: 8381807

Abstract

Samples of cervical secretions and serum from 30 women with genital condylomas and 30 age-matched controls were tested for the presence of immunoglobulin A (IgA) and IgG antibodies against a panel of papillomavirus-derived antigens. The same cervical samples were also analyzed for presence of human papillomavirus (HPV) DNA by Southern blotting and polymerase chain reaction. By Southern blotting HPV DNA was detected in 8 of 30 patients with condylomas and 2 of 30 controls, and by the polymerase chain reaction HPV DNA was detected in 14 of 30 patients with condylomas and 5 of 30 controls. A total of 18 of 29 patients with condylomas and 8 of 28 controls had IgA antibodies in cervical secretions to an E2 synthetic peptide, and 17 of 29 patients with condylomas and 5 of 28 controls had local IgA antibodies to an E7 peptide (P < 0.025 and P < 0.005, respectively). The results suggest that measurement of local antibody production against selected HPV antigens may be useful in the study of HPV immunology and, possibly, for the diagnosis of HPV infection.

Full text

PDF
192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bleul C., Müller M., Frank R., Gausepohl H., Koldovsky U., Mgaya H. N., Luande J., Pawlita M., ter Meulen J., Viscidi R. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients. J Clin Microbiol. 1991 Aug;29(8):1579–1588. doi: 10.1128/jcm.29.8.1579-1588.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dillner J., Dillner L., Robb J., Willems J., Jones I., Lancaster W., Smith R., Lerner R. A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci U S A. 1989 May;86(10):3838–3841. doi: 10.1073/pnas.86.10.3838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dillner J., Dillner L., Utter G., Eklund C., Rotola A., Costa S., DiLuca D. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. Int J Cancer. 1990 Mar 15;45(3):529–535. doi: 10.1002/ijc.2910450326. [DOI] [PubMed] [Google Scholar]
  4. Dillner J. Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int J Cancer. 1990 Oct 15;46(4):703–711. doi: 10.1002/ijc.2910460426. [DOI] [PubMed] [Google Scholar]
  5. Dillner L., Bekassy Z., Jonsson N., Moreno-Lopez J., Blomberg J. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer. 1989 Jan 15;43(1):36–40. doi: 10.1002/ijc.2910430109. [DOI] [PubMed] [Google Scholar]
  6. Dillner L., Heino P., Moreno-Lopez J., Dillner J. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses. J Virol. 1991 Dec;65(12):6862–6871. doi: 10.1128/jvi.65.12.6862-6871.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dillner L., Moreno-Lopez J., Dillner J. Serological responses to papillomavirus group-specific antigens in women with neoplasia of the cervix uteri. J Clin Microbiol. 1990 Mar;28(3):624–627. doi: 10.1128/jcm.28.3.624-627.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. A. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. J Virol. 1988 Jun;62(6):2115–2123. doi: 10.1128/jvi.62.6.2115-2123.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jenison S. A., Yu X. P., Valentine J. M., Galloway D. A. Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. J Virol. 1989 Feb;63(2):809–818. doi: 10.1128/jvi.63.2.809-818.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jenison S. A., Yu X. P., Valentine J. M., Koutsky L. A., Christiansen A. E., Beckmann A. M., Galloway D. A. Evidence of prevalent genital-type human papillomavirus infections in adults and children. J Infect Dis. 1990 Jul;162(1):60–69. doi: 10.1093/infdis/162.1.60. [DOI] [PubMed] [Google Scholar]
  11. Jochmus-Kudielka I., Schneider A., Braun R., Kimmig R., Koldovsky U., Schneweis K. E., Seedorf K., Gissmann L. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst. 1989 Nov 15;81(22):1698–1704. doi: 10.1093/jnci/81.22.1698. [DOI] [PubMed] [Google Scholar]
  12. Krchnák V., Vágner J., Suchánková A., Krcmár M., Ritterová L., Vonka V. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J Gen Virol. 1990 Nov;71(Pt 11):2719–2724. doi: 10.1099/0022-1317-71-11-2719. [DOI] [PubMed] [Google Scholar]
  13. Köchel H. G., Monazahian M., Sievert K., Höhne M., Thomssen C., Teichmann A., Arendt P., Thomssen R. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls. Int J Cancer. 1991 Jul 9;48(5):682–688. doi: 10.1002/ijc.2910480509. [DOI] [PubMed] [Google Scholar]
  14. Lehtinen M., Leminen A., Kuoppala T., Tiikkainen M., Lehtinen T., Lehtovirta P., Punnonen R., Vesterinen E., Paavonen J. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma. J Med Virol. 1992 Jul;37(3):180–186. doi: 10.1002/jmv.1890370306. [DOI] [PubMed] [Google Scholar]
  15. Lehtinen M., Leminen A., Paavonen J., Lehtovirta P., Hyöty H., Vesterinen E., Dillner J. Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma. J Clin Pathol. 1992 Jun;45(6):494–497. doi: 10.1136/jcp.45.6.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lim P. S., Jenson A. B., Cowsert L., Nakai Y., Lim L. Y., Jin X. W., Sundberg J. P. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J Infect Dis. 1990 Dec;162(6):1263–1269. doi: 10.1093/infdis/162.6.1263. [DOI] [PubMed] [Google Scholar]
  17. Linde A., Kallin B., Dillner J., Andersson J., Jägdahl L., Lindvall A., Wahren B. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. J Infect Dis. 1990 May;161(5):903–909. doi: 10.1093/infdis/161.5.903. [DOI] [PubMed] [Google Scholar]
  18. Lorincz A. T., Lancaster W. D., Temple G. F. Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol. 1986 Apr;58(1):225–229. doi: 10.1128/jvi.58.1.225-229.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lorincz A. T., Reid R., Jenson A. B., Greenberg M. D., Lancaster W., Kurman R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992 Mar;79(3):328–337. doi: 10.1097/00006250-199203000-00002. [DOI] [PubMed] [Google Scholar]
  20. Mann V. M., de Lao S. L., Brenes M., Brinton L. A., Rawls J. A., Green M., Reeves W. C., Rawls W. E. Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Res. 1990 Dec 15;50(24):7815–7819. [PubMed] [Google Scholar]
  21. Meisels A., Morin C., Casas-Cordero M. Human papillomavirus infection of the uterine cervix. Int J Gynecol Pathol. 1982;1(1):75–94. doi: 10.1097/00004347-198201000-00009. [DOI] [PubMed] [Google Scholar]
  22. Pfister H. Human papillomaviruses and genital cancer. Adv Cancer Res. 1987;48:113–147. doi: 10.1016/s0065-230x(08)60691-0. [DOI] [PubMed] [Google Scholar]
  23. Reeves W. C., Rawls J. A., Green M., Rawls W. E. Antibodies to human papillomavirus type 16 in patients with cervical neoplasia. Lancet. 1990 Mar 3;335(8688):551–552. doi: 10.1016/0140-6736(90)90793-5. [DOI] [PubMed] [Google Scholar]
  24. Shah K. V., Buscema J. Genital warts, papillomaviruses, and genital malignancies. Annu Rev Med. 1988;39:371–379. doi: 10.1146/annurev.me.39.020188.002103. [DOI] [PubMed] [Google Scholar]
  25. Snyder K. A., Barber S. R., Symbula M., Taylor P. T., Crum C. P., Roche J. K. Binding by immunoglobulin to the HPV-16-derived proteins L1 and E4 in cervical secretions of women with HPV-related cervical disease. Cancer Res. 1991 Aug 15;51(16):4423–4429. [PubMed] [Google Scholar]
  26. Wikström A., Eklund C., Von Krogh G., Lidbrink P., Dillner J. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata. J Clin Microbiol. 1992 Jul;30(7):1795–1800. doi: 10.1128/jcm.30.7.1795-1800.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. de Villiers E. M. Heterogeneity of the human papillomavirus group. J Virol. 1989 Nov;63(11):4898–4903. doi: 10.1128/jvi.63.11.4898-4903.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES